Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Change in Accured Expenses (2016 - 2025)

HealthLynked (HLYK) has disclosed Change in Accured Expenses for 10 consecutive years, with $85886.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Accured Expenses rose 208.66% to $85886.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $349230.0, a 315.2% increase, with the full-year FY2024 number at $70911.0, up 109.09% from a year prior.
  • Change in Accured Expenses was $85886.0 for Q3 2025 at HealthLynked, down from $90810.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $891221.0 in Q3 2021 to a low of -$939448.0 in Q4 2021.
  • A 5-year average of $12759.4 and a median of $85886.0 in 2025 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: soared 6194.38% in 2021, then crashed 1531.64% in 2023.
  • HealthLynked's Change in Accured Expenses stood at -$939448.0 in 2021, then skyrocketed by 141.3% to $388010.0 in 2022, then crashed by 170.32% to -$272831.0 in 2023, then surged by 85.47% to -$39638.0 in 2024, then surged by 316.68% to $85886.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Change in Accured Expenses are $85886.0 (Q3 2025), $90810.0 (Q2 2025), and $212172.0 (Q1 2025).